Pragmatic Randomized Study of Afatinib Versus Chemotherapy for Patients With Non–Small Cell Lung Cancer With Uncommon Epidermal Growth Factor Receptor Mutations: ACHILLES/TORG1834
Afatinib should be considered the standard initial therapy for patients with NSCLC with sensitizing uncommon <i>EGFR</i> mutations.
Authors
- Yoshimasa Shiraishi (ORCID: https://orcid.org/0000-0001-5015-193X)
- Yasuhiro Gotô (ORCID: https://orcid.org/0000-0003-2235-8567)
- Toshihide Yokoyama (ORCID: https://orcid.org/0000-0002-5595-5010)
- Yuichi Takiguchi (ORCID: https://orcid.org/0000-0001-6059-7476)
- Toshihiro Misumi (ORCID: https://orcid.org/0000-0001-8339-2895)
- Hiroshi Tanaka (ORCID: https://orcid.org/0000-0001-7057-813X)
- Kazumi Nishino (ORCID: https://orcid.org/0000-0003-2000-7472)
- Hiroshige Yoshioka (ORCID: https://orcid.org/0000-0001-7724-0481)
- Satoru Miura (ORCID: https://orcid.org/0000-0001-7868-6661)
- Ou Yamaguchi (ORCID: https://orcid.org/0000-0001-7194-6459)
- Eiki Ichihara (ORCID: https://orcid.org/0000-0002-2966-106X)
- Takayasu Kurata (ORCID: https://orcid.org/0000-0003-4123-3567)
- Hidehito Horinouchi (ORCID: https://orcid.org/0000-0001-9090-801X)
- Shoichi Kuyama (ORCID: https://orcid.org/0000-0002-6079-3511)
- Tatsuro Fukuhara (ORCID: https://orcid.org/0000-0003-0440-470X)
- Satoshi Ikeda (ORCID: https://orcid.org/0000-0001-5203-7911)
- Yuki Sato (ORCID: https://orcid.org/0000-0002-7829-7524)
- Naoki Furuya (ORCID: https://orcid.org/0000-0001-7162-5946)
- Takaaki Tokito (ORCID: https://orcid.org/0000-0002-8429-2287)
- Hiroaki Akamatsu (ORCID: https://orcid.org/0000-0001-5856-5512)
- Terufumi Kato (ORCID: https://orcid.org/0000-0002-5853-1424)
- Kentaro Tanaka (ORCID: https://orcid.org/0000-0003-4602-4465)
- Katsuhiko Naoki (ORCID: https://orcid.org/0000-0002-9637-1388)
- Hiroaki Okamoto (ORCID: https://orcid.org/0000-0003-3110-5545)
- Masahide Mori
Institutions
- Kurume University (JP)
- Kagoshima University (JP)
- Kansai Medical University (JP)
- Kyushu University (JP)
- Fujita Health University (JP)
- St. Marianna University School of Medicine (JP)
- Wakayama Medical University (JP)
- Kanagawa Prefectural Hospital Organization (JP)
- Kurashiki Central Hospital (JP)
- Niigata Cancer Center Hospital (JP)
- Chiba University Hospital (JP)
- Okayama University Hospital (JP)
- Toneyama National Hospital (JP)
- Miyagi Prefectural Hospital Organization (JP)
- Iwakuni Medical Center (JP)
- Yokohama Municipal Citizen's Hospital (JP)
- National Cancer Center Hospital East (JP)
- Kanagawa Cardiovascular and Respiratory Center (JP)
- Osaka International Cancer Institute (JP)
- Kobe City Medical Center General Hospital (JP)
- Sanno Medical Center (JP)
- Kanagawa Cancer Center
- Kitasato University (JP)
- Saitama Medical University (JP)
Publication Details
- Journal
- Journal of Clinical Oncology
- Published
- 2025-04-16
- DOI
- https://doi.org/10.1200/jco-24-02007
- Citations
- 19
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 28.85